Lifevantage Corporation
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, weight management, pre and pro-biotics and skin and hair care products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 and Omega-7 fatty acids, and vitamin D3… Read more
Lifevantage Corporation (LFVN) - Total Liabilities
Latest total liabilities as of December 2025: $28.18 Million USD
Based on the latest financial reports, Lifevantage Corporation (LFVN) has total liabilities worth $28.18 Million USD as of December 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Lifevantage Corporation - Total Liabilities Trend (1997–2025)
This chart illustrates how Lifevantage Corporation's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Lifevantage Corporation Competitors by Total Liabilities
The table below lists competitors of Lifevantage Corporation ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
NRX Pharmaceuticals Inc
NASDAQ:NRXP
|
USA | $40.75 Million |
|
Many Peaks Minerals Ltd
AU:MPK
|
Australia | AU$2.07 Million |
|
EUWAX Aktiengesellschaft
F:EUX
|
Germany | €134.28 Million |
|
Digital Brands Group Inc
NASDAQ:DBGIW
|
USA | $23.27 Million |
|
Shougang Concord Century Holdings Limited
F:CW7
|
Germany | €1.80 Billion |
|
Vascon Engineers Limited
NSE:VASCONEQ
|
India | ₹10.70 Billion |
|
Cementos Bio-B
SN:CEMENTOS
|
Chile | CL$239.33 Billion |
|
e-Credible Co. Ltd
KQ:092130
|
Korea | ₩10.13 Billion |
Liability Composition Analysis (1997–2025)
This chart breaks down Lifevantage Corporation's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.03 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.85 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.46 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Lifevantage Corporation's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Lifevantage Corporation (1997–2025)
The table below shows the annual total liabilities of Lifevantage Corporation from 1997 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | $37.32 Million | +8.77% |
| 2024-06-30 | $34.31 Million | +9.00% |
| 2023-06-30 | $31.47 Million | -19.69% |
| 2022-06-30 | $39.19 Million | -6.52% |
| 2021-06-30 | $41.92 Million | +63.62% |
| 2020-06-30 | $25.62 Million | -8.73% |
| 2019-06-30 | $28.07 Million | -3.84% |
| 2018-06-30 | $29.20 Million | -4.97% |
| 2017-06-30 | $30.72 Million | -19.42% |
| 2016-06-30 | $38.13 Million | +1.53% |
| 2015-06-30 | $37.55 Million | -24.91% |
| 2014-06-30 | $50.01 Million | +132.18% |
| 2013-06-30 | $21.54 Million | +32.59% |
| 2012-06-30 | $16.24 Million | -51.23% |
| 2011-06-30 | $33.31 Million | +48.68% |
| 2010-06-30 | $22.40 Million | +78.22% |
| 2009-06-30 | $12.57 Million | +810.99% |
| 2008-06-30 | $1.38 Million | +14.90% |
| 2007-06-30 | $1.20 Million | -44.49% |
| 2006-06-30 | $2.16 Million | +150.03% |
| 2005-06-30 | $865.20K | +5878.85% |
| 2004-06-30 | $14.47K | +113.59% |
| 2003-06-30 | $6.78K | +409.78% |
| 2002-06-30 | $1.33K | -94.46% |
| 2000-06-30 | $24.00K | -84.63% |
| 1999-06-30 | $156.18K | -23.05% |
| 1998-06-30 | $202.97K | +13.50% |
| 1997-06-30 | $178.82K | -- |